Cargando…

Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma

BACKGROUND: Peritumoral activated hepatic stellate cells (HSCs) are versatile myofibroblast-like cells closely related with hepatocellular carcinoma (HCC) progression. So far, comprehensive comparison of gene expression of human HSCs during hepatocarcinogenesis is scanty. Therefore, we identified th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Rui, Wu, Han, Yi, Yong, Wang, Jia-Xing, Cai, Xiao-Yan, He, Hong-Wei, Cheng, Yun-Feng, Zhou, Jian, Fan, Jia, Sun, Jian, Qiu, Shuang-Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654985/ https://www.ncbi.nlm.nih.gov/pubmed/23601182 http://dx.doi.org/10.1186/1756-9966-32-22

Ejemplares similares

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

Dexmedetomidine promotes the progression of hepatocellular carcinoma through hepatic stellate cell activation
por: Chen, Peng, et al.
Publicado: (2020)

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis
por: Li, Yaqun, et al.
Publicado: (2022)

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
por: Liao, Xia, et al.
Publicado: (2019)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis
por: He, Lu, et al.
Publicado: (2020)

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
por: Hu, Jie, et al.
Publicado: (2011)

HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection
por: Liao, Rui, et al.
Publicado: (2018)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma
por: Zhou, Yuan, et al.
Publicado: (2023)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma
por: Yang, Liu, et al.
Publicado: (2018)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma
por: Liao, Rui, et al.
Publicado: (2021)

Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma
por: Quiroz Reyes, Adriana G., et al.
Publicado: (2023)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

Metabolomic profiling for identification of metabolites and relevant pathways for taurine in hepatic stellate cells
por: Deng, Xin, et al.
Publicado: (2017)

Nuclear GAPDH is vital for hypoxia-induced hepatic stellate cell apoptosis and is indicative of aggressive hepatocellular carcinoma behavior
por: Gong, Yihang, et al.
Publicado: (2019)

Obstacles and opportunities in the prevention and treatment of HBV-related hepatocellular carcinoma
por: Liao, Yong
Publicado: (2020)

Probing the Hepatic Progenitor Cell in Human Hepatocellular Carcinoma
por: Jia, Shu-Qin, et al.
Publicado: (2013)

A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Association of TIP30 expression and prognosis of hepatocellular carcinoma in patients with HBV infection
por: Zhang, Xia, et al.
Publicado: (2016)

Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinoma
por: JIANG, JIA-HAO, et al.
Publicado: (2014)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
por: Xie, Shucai, et al.
Publicado: (2019)

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence
por: Zhou, Shao-Lai, et al.
Publicado: (2022)

Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China
por: Liao, Rui, et al.
Publicado: (2016)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Integrated network analysis of transcriptomic and protein-protein interaction data in taurine-treated hepatic stellate cells
por: Liang, Xing-Qiu, et al.
Publicado: (2019)

HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B
por: Zhong, Rong, et al.
Publicado: (2012)

Hepatic Stellate Cells Secreted Hepatocyte Growth Factor Contributes to the Chemoresistance of Hepatocellular Carcinoma
por: Yu, Guofeng, et al.
Publicado: (2013)

Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
por: Zhu, Bing, et al.
Publicado: (2015)

Rat hepatic stellate cells alter the gene expression profile and promote the growth, migration and invasion of hepatocellular carcinoma cells
por: WANG, ZHI-MING, et al.
Publicado: (2014)

HK1 from hepatic stellate cell–derived extracellular vesicles promotes progression of hepatocellular carcinoma
por: Chen, Qi-tao, et al.
Publicado: (2022)

Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b4hstrj68n02j0827k3h6sprli